Article Details
Retrieved on: 2022-06-25 01:22:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's development efforts were dealt a blow in May, when trial data showed its cancer drug tiragolumab failed to meaningfully slow disease ...
Article found on: www.pharmalive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here